ENTRY       4790              CDS       T01001
NAME        NFKB1, CVID12, EBP-1, KBF1, NF-kB1, NF-kappa-B, NF-kappaB, NFKB-p105, NFKB-p50, NFkappaB, p105, p50
DEFINITION  (RefSeq) nuclear factor kappa B subunit 1
ORTHOLOGY   K02580  nuclear factor NF-kappa-B p105 subunit
ORGANISM    hsa  Homo sapiens (human)
PATHWAY     hsa01523  Antifolate resistance
            hsa04010  MAPK signaling pathway
            hsa04014  Ras signaling pathway
            hsa04024  cAMP signaling pathway
            hsa04062  Chemokine signaling pathway
            hsa04064  NF-kappa B signaling pathway
            hsa04066  HIF-1 signaling pathway
            hsa04071  Sphingolipid signaling pathway
            hsa04151  PI3K-Akt signaling pathway
            hsa04210  Apoptosis
            hsa04211  Longevity regulating pathway
            hsa04218  Cellular senescence
            hsa04380  Osteoclast differentiation
            hsa04620  Toll-like receptor signaling pathway
            hsa04621  NOD-like receptor signaling pathway
            hsa04622  RIG-I-like receptor signaling pathway
            hsa04623  Cytosolic DNA-sensing pathway
            hsa04657  IL-17 signaling pathway
            hsa04658  Th1 and Th2 cell differentiation
            hsa04659  Th17 cell differentiation
            hsa04660  T cell receptor signaling pathway
            hsa04662  B cell receptor signaling pathway
            hsa04668  TNF signaling pathway
            hsa04722  Neurotrophin signaling pathway
            hsa04917  Prolactin signaling pathway
            hsa04920  Adipocytokine signaling pathway
            hsa04926  Relaxin signaling pathway
            hsa04931  Insulin resistance
            hsa04932  Non-alcoholic fatty liver disease (NAFLD)
            hsa04933  AGE-RAGE signaling pathway in diabetic complications
            hsa05030  Cocaine addiction
            hsa05120  Epithelial cell signaling in Helicobacter pylori infection
            hsa05131  Shigellosis
            hsa05132  Salmonella infection
            hsa05133  Pertussis
            hsa05134  Legionellosis
            hsa05140  Leishmaniasis
            hsa05142  Chagas disease (American trypanosomiasis)
            hsa05145  Toxoplasmosis
            hsa05146  Amoebiasis
            hsa05152  Tuberculosis
            hsa05160  Hepatitis C
            hsa05161  Hepatitis B
            hsa05162  Measles
            hsa05164  Influenza A
            hsa05165  Human papillomavirus infection
            hsa05166  HTLV-I infection
            hsa05167  Kaposi's sarcoma-associated herpesvirus infection
            hsa05168  Herpes simplex infection
            hsa05169  Epstein-Barr virus infection
            hsa05200  Pathways in cancer
            hsa05202  Transcriptional misregulation in cancer
            hsa05203  Viral carcinogenesis
            hsa05206  MicroRNAs in cancer
            hsa05212  Pancreatic cancer
            hsa05215  Prostate cancer
            hsa05220  Chronic myeloid leukemia
            hsa05221  Acute myeloid leukemia
            hsa05222  Small cell lung cancer
            hsa05321  Inflammatory bowel disease (IBD)
            hsa05418  Fluid shear stress and atherosclerosis
MODULE      hsa_M00686  Toll-like receptor signaling
DRUG_TARGET Iguratimod: D01146
BRITE       KEGG Orthology (KO) [BR:hsa00001]
             Environmental Information Processing
              Signal transduction
               04014 Ras signaling pathway
                4790 (NFKB1)
               04010 MAPK signaling pathway
                4790 (NFKB1)
               04064 NF-kappa B signaling pathway
                4790 (NFKB1)
               04668 TNF signaling pathway
                4790 (NFKB1)
               04066 HIF-1 signaling pathway
                4790 (NFKB1)
               04071 Sphingolipid signaling pathway
                4790 (NFKB1)
               04024 cAMP signaling pathway
                4790 (NFKB1)
               04151 PI3K-Akt signaling pathway
                4790 (NFKB1)
             Cellular Processes
              Cell growth and death
               04210 Apoptosis
                4790 (NFKB1)
               04218 Cellular senescence
                4790 (NFKB1)
             Organismal Systems
              Immune system
               04620 Toll-like receptor signaling pathway
                4790 (NFKB1)
               04621 NOD-like receptor signaling pathway
                4790 (NFKB1)
               04622 RIG-I-like receptor signaling pathway
                4790 (NFKB1)
               04623 Cytosolic DNA-sensing pathway
                4790 (NFKB1)
               04660 T cell receptor signaling pathway
                4790 (NFKB1)
               04658 Th1 and Th2 cell differentiation
                4790 (NFKB1)
               04659 Th17 cell differentiation
                4790 (NFKB1)
               04657 IL-17 signaling pathway
                4790 (NFKB1)
               04662 B cell receptor signaling pathway
                4790 (NFKB1)
               04062 Chemokine signaling pathway
                4790 (NFKB1)
              Endocrine system
               04920 Adipocytokine signaling pathway
                4790 (NFKB1)
               04917 Prolactin signaling pathway
                4790 (NFKB1)
               04926 Relaxin signaling pathway
                4790 (NFKB1)
              Nervous system
               04722 Neurotrophin signaling pathway
                4790 (NFKB1)
              Development
               04380 Osteoclast differentiation
                4790 (NFKB1)
              Aging
               04211 Longevity regulating pathway - mammal
                4790 (NFKB1)
             Human Diseases
              Cancers
               05200 Pathways in cancer
                4790 (NFKB1)
               05202 Transcriptional misregulation in cancers
                4790 (NFKB1)
               05206 MicroRNAs in cancer
                4790 (NFKB1)
               05203 Viral carcinogenesis
                4790 (NFKB1)
               05212 Pancreatic cancer
                4790 (NFKB1)
               05221 Acute myeloid leukemia
                4790 (NFKB1)
               05220 Chronic myeloid leukemia
                4790 (NFKB1)
               05215 Prostate cancer
                4790 (NFKB1)
               05222 Small cell lung cancer
                4790 (NFKB1)
              Immune diseases
               05321 Inflammatiory bowel disease (IBD)
                4790 (NFKB1)
              Substance dependence
               05030 Cocaine addiction
                4790 (NFKB1)
              Cardiovascular diseases
               05418 Fluid shear stress and atherosclerosis
                4790 (NFKB1)
              Endocrine and metabolic diseases
               04932 Non-alcoholic fatty liver disease (NAFLD)
                4790 (NFKB1)
               04931 Insulin resistance
                4790 (NFKB1)
               04933 AGE-RAGE signaling pathway in diabetic complications
                4790 (NFKB1)
              Infectious diseases
               05120 Epithelial cell signaling in Helicobacter pylori infection
                4790 (NFKB1)
               05132 Salmonella infection
                4790 (NFKB1)
               05131 Shigellosis
                4790 (NFKB1)
               05133 Pertussis
                4790 (NFKB1)
               05134 Legionellosis
                4790 (NFKB1)
               05152 Tuberculosis
                4790 (NFKB1)
               05166 HTLV-I infection
                4790 (NFKB1)
               05162 Measles
                4790 (NFKB1)
               05164 Influenza A
                4790 (NFKB1)
               05161 Hepatitis B
                4790 (NFKB1)
               05160 Hepatitis C
                4790 (NFKB1)
               05168 Herpes simplex infection
                4790 (NFKB1)
               05167 Kaposi's sarcoma-associated herpesvirus infection
                4790 (NFKB1)
               05169 Epstein-Barr virus infection
                4790 (NFKB1)
               05165 Human papillomavirus infection
                4790 (NFKB1)
               05146 Amoebiasis
                4790 (NFKB1)
               05145 Toxoplasmosis
                4790 (NFKB1)
               05140 Leishmaniasis
                4790 (NFKB1)
               05142 Chagas disease (American trypanosomiasis)
                4790 (NFKB1)
              Drug resistance
               01523 Antifolate resistance
                4790 (NFKB1)
            Transcription factors [BR:hsa03000]
             Eukaryotic Type
              beta-Scaffold factors with minor groove contacts
               RHR (Rel homology region) Rel/Ankyrin
                4790 (NFKB1)
POSITION    4q24
MOTIF       Pfam: RHD_DNA_bind RHD_dimer Ank_2 Ank_4 Ank Ank_3 Ank_5 Death
DBLINKS     NCBI-GeneID: 4790
            NCBI-ProteinID: NP_001158884
            OMIM: 164011
            HGNC: 7794
            Ensembl: ENSG00000109320
            Vega: OTTHUMG00000161080
            Pharos: P19838(Tchem)
            UniProt: P19838 A0A024RDJ4
STRUCTURE   PDB: 1SVC 1NFI 2O61 3GUT 2DBF
AASEQ       968
            MAEDDPYLGRPEQMFHLDPSLTHTIFNPEVFQPQMALPTDGPYLQILEQPKQRGFRFRYV
            CEGPSHGGLPGASSEKNKKSYPQVKICNYVGPAKVIVQLVTNGKNIHLHAHSLVGKHCED
            GICTVTAGPKDMVVGFANLGILHVTKKKVFETLEARMTEACIRGYNPGLLVHPDLAYLQA
            EGGGDRQLGDREKELIRQAALQQTKEMDLSVVRLMFTAFLPDSTGSFTRRLEPVVSDAIY
            DSKAPNASNLKIVRMDRTAGCVTGGEEIYLLCDKVQKDDIQIRFYEEEENGGVWEGFGDF
            SPTDVHRQFAIVFKTPKYKDINITKPASVFVQLRRKSDLETSEPKPFLYYPEIKDKEEVQ
            RKRQKLMPNFSDSFGGGSGAGAGGGGMFGSGGGGGGTGSTGPGYSFPHYGFPTYGGITFH
            PGTTKSNAGMKHGTMDTESKKDPEGCDKSDDKNTVNLFGKVIETTEQDQEPSEATVGNGE
            VTLTYATGTKEESAGVQDNLFLEKAMQLAKRHANALFDYAVTGDVKMLLAVQRHLTAVQD
            ENGDSVLHLAIIHLHSQLVRDLLEVTSGLISDDIINMRNDLYQTPLHLAVITKQEDVVED
            LLRAGADLSLLDRLGNSVLHLAAKEGHDKVLSILLKHKKAALLLDHPNGDGLNAIHLAMM
            SNSLPCLLLLVAAGADVNAQEQKSGRTALHLAVEHDNISLAGCLLLEGDAHVDSTTYDGT
            TPLHIAAGRGSTRLAALLKAAGADPLVENFEPLYDLDDSWENAGEDEGVVPGTTPLDMAT
            SWQVFDILNGKPYEPEFTSDDLLAQGDMKQLAEDVKLQLYKLLEIPDPDKNWATLAQKLG
            LGILNNAFRLSPAPSKTLMDNYEVSGGTVRELVEALRQMGYTEAIEVIQAASSPVKTTSQ
            AHSLPLSPASTRQQIDELRDSDSVCDSGVETSFRKLSFTESLTSGASLLTLNKMPHDYGQ
            EGPLEGKI
NTSEQ       2907
            atggcagaagatgatccatatttgggaaggcctgaacaaatgtttcatttggatccttct
            ttgactcatacaatatttaatccagaagtatttcaaccacagatggcactgccaacagat
            ggcccataccttcaaatattagagcaacctaaacagagaggatttcgtttccgttatgta
            tgtgaaggcccatcccatggtggactacctggtgcctctagtgaaaagaacaagaagtct
            taccctcaggtcaaaatctgcaactatgtgggaccagcaaaggttattgttcagttggtc
            acaaatggaaaaaatatccacctgcatgcccacagcctggtgggaaaacactgtgaggat
            gggatctgcactgtaactgctggacccaaggacatggtggtcggcttcgcaaacctgggt
            atacttcatgtgacaaagaaaaaagtatttgaaacactggaagcacgaatgacagaggcg
            tgtataaggggctataatcctggactcttggtgcaccctgaccttgcctatttgcaagca
            gaaggtggaggggaccggcagctgggagatcgggaaaaagagctaatccgccaagcagct
            ctgcagcagaccaaggagatggacctcagcgtggtgcggctcatgtttacagcttttctt
            ccggatagcactggcagcttcacaaggcgcctggaacccgtggtatcagacgccatctat
            gacagtaaagcccccaatgcatccaacttgaaaattgtaagaatggacaggacagctgga
            tgtgtgactggaggggaggaaatttatcttctttgtgacaaagttcagaaagatgacatc
            cagattcgattttatgaagaggaagaaaatggtggagtctgggaaggatttggagatttt
            tcccccacagatgttcatagacaatttgccattgtcttcaaaactccaaagtataaagat
            attaatattacaaaaccagcctctgtgtttgtccagcttcggaggaaatctgacttggaa
            actagtgaaccaaaacctttcctctactatcctgaaatcaaagataaagaagaagtgcag
            aggaaacgtcagaagctcatgcccaatttttcggatagtttcggcggtggtagtggtgct
            ggagctggaggcggaggcatgtttggtagtggcggtggaggagggggcactggaagtaca
            ggtccagggtatagcttcccacactatggatttcctacttatggtgggattactttccat
            cctggaactactaaatctaatgctgggatgaagcatggaaccatggacactgaatctaaa
            aaggaccctgaaggttgtgacaaaagtgatgacaaaaacactgtaaacctctttgggaaa
            gttattgaaaccacagagcaagatcaggagcccagcgaggccaccgttgggaatggtgag
            gtcactctaacgtatgcaacaggaacaaaagaagagagtgctggagttcaggataacctc
            tttctagagaaggctatgcagcttgcaaagaggcatgccaatgcccttttcgactacgcg
            gtgacaggagacgtgaagatgctgctggccgtccagcgccatctcactgctgtgcaggat
            gagaatggggacagtgtcttacacttagcaatcatccaccttcattctcaacttgtgagg
            gatctactagaagtcacatctggtttgatttctgatgacattatcaacatgagaaatgat
            ctgtaccagacgcccttgcacttggcagtgatcactaagcaggaagatgtggtggaggat
            ttgctgagggctggggccgacctgagccttctggaccgcttgggtaactctgttttgcac
            ctagctgccaaagaaggacatgataaagttctcagtatcttactcaagcacaaaaaggca
            gcactacttcttgaccaccccaacggggacggtctgaatgccattcatctagccatgatg
            agcaatagcctgccatgtttgctgctgctggtggccgctggggctgacgtcaatgctcag
            gagcagaagtccgggcgcacagcactgcacctggctgtggagcacgacaacatctcattg
            gcaggctgcctgctcctggagggtgatgcccatgtggacagtactacctacgatggaacc
            acacccctgcatatagcagctgggagagggtccaccaggctggcagctcttctcaaagca
            gcaggagcagatcccctggtggagaactttgagcctctctatgacctggatgactcttgg
            gaaaatgcaggagaggatgaaggagttgtgcctggaaccacgcctctagatatggccacc
            agctggcaggtatttgacatattaaatgggaaaccatatgagccagagtttacatctgat
            gatttactagcacaaggagacatgaaacagctggctgaagatgtgaagctgcagctgtat
            aagttactagaaattcctgatccagacaaaaactgggctactctggcgcagaaattaggt
            ctggggatacttaataatgccttccggctgagtcctgctccttccaaaacacttatggac
            aactatgaggtctctgggggtacagtcagagagctggtggaggccctgagacaaatgggc
            tacaccgaagcaattgaagtgatccaggcagcctccagcccagtgaagaccacctctcag
            gcccactcgctgcctctctcgcctgcctccacaaggcagcaaatagacgagctccgagac
            agtgacagtgtctgcgacagcggcgtggagacatccttccgcaaactcagctttaccgag
            tctctgaccagtggtgcctcactgctaactctcaacaaaatgccccatgattatgggcag
            gaaggacctctagaaggcaaaatttag
///
